查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853389

動物即時診斷市場（按動物類型、檢測類型、最終用戶、技術、應用和樣本類型分類）—2025-2032年全球預測

Veterinary Point Of Care Diagnostics Market by Animal Type, Test Type, End User, Technology, Application, Sample Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫即時診斷市場規模將達到 50.3 億美元，複合年成長率為 12.58%。

關鍵市場統計數據
基準年2024年 19.4億美元
預計年份：2025年 21.9億美元
預測年份 2032 50.3億美元
複合年成長率（%） 12.58%

本文簡要介紹了床邊診斷和燒傷場診斷如何重塑當今的獸醫醫療服務和臨床決策。

動物照護現場診斷正迅速從一種輔助設備發展成為動物醫療保健服務的核心要素。獸醫和畜牧管理者越來越需要在床邊或畜舍獲得快速可靠的檢測結果，以便立即做出臨床決策、提高診療效率並減少集中式實驗室帶來的後勤障礙。攜帶式分析化學、小型化分析儀和整合數位輸出技術的進步縮短了周轉時間，使得在治療時間和地點即可獲得有效的診斷結果成為可能。

這一演變是由多種因素共同推動的。伴侶動物數量的成長以及人們對寵物健康投入意願的提高正在重塑臨床預期；而在畜牧業領域，最佳化牛健康和生物安全的壓力日益增大，促使農場管理者採用更積極主動的診斷流程。同時，免疫測量、分子平台和感測器技術的成熟使得在小型設備中實現更高的分析性能成為可能。部分地區的監管政策更加明確，獸醫專業人員的訓練課程也更加完善，降低了技術應用的門檻。

綜上所述，這些動態因素正助力獸醫縮小從臨床懷疑到檢驗的差距，從而支持更早的干涉、更有針對性的治療，並顯著改善動物福利和營運效率。本執行摘要探討了變革性轉變、細分市場的細微差別、區域差異、公司應對措施，以及領導者在進入這個充滿活力的市場時應考慮的策略建議。

本文分析了正在重塑照護現場獸醫診斷和行業經營模式的關鍵技術、臨床和商業性變革。

獸醫照護現場診斷領域正經歷一場變革性的轉變，重塑價值鏈、臨床工作流程和投資重點。其中一個顯著的變化是從一次性側向流動檢測設備轉向更先進的基於讀卡器和無讀卡器的檢測設備，這些設備能夠實現定量輸出、互聯互通和結果標準化。這項轉變有助於與診所管理系統和遠距分診服務整合，使臨床醫生能夠做出基於數據的可靠決策，並擴大遠距和門診環境下的診斷範圍。

同時，由於簡化的樣本製備、等溫擴增和基於試劑盒的耗材，分子診斷正從中心實驗室轉移到更貼近患者的場所。更靈敏的檢測方法的廣泛應用正在改變伴侶動物和牲畜感染疾病管理的診斷路徑，從而實現更快的疫情控制和更有針對性的治療。人工智慧和雲端分析為原始輸出結果增添了一層解讀空間，幫助臨床醫生確定病例優先順序並更早識別流行病學訊號。

隨著經營模式的演變，製造商和經銷商正採用以服務為中心的策略，將儀器與試劑、校準服務和數位訂閱捆綁銷售，以鎖定終身價值並提高可預測性。這種轉變迫使傳統供應商加快創新週期，並要求新參與企業證明其具備臨床檢驗、符合法規要求以及經濟高效的服務營運能力。最終，這將形成一個更互聯、靈活且具有臨床影響力的獸醫診斷生態系統。

2025年關稅調整如何改變了獸醫診斷設備和耗材的供應鏈、定價策略和採購選擇

2025年實施的關稅調整的累積影響對整個獸醫診斷生態系統的籌資策略、定價機制和供應鏈韌性產生了重大影響。關稅波動增加了進口分析儀、讀取模組和關鍵試劑的到岸成本，這些產品通常在海外高度專業化的工廠生產。對於利潤微薄的終端用戶，例如門診和小型診斷實驗室，成本增加迫使他們重新調整服務價格並延長資本設備的更換週期。

製造商和經銷商的應對措施包括加速本地化和雙源籌資策略。一些企業將大批量消耗品的生產轉移到區域性代工製造商，而其他企業則優先考慮庫存避險和多層分銷，以緩衝短期波動。雖然這些策略提高了應對力，但也增加了營運成本，並使庫存管理更加複雜。同時，關稅相關的成本壓力促使企業重新設計產品，以減少對高關稅零件的依賴，並最佳化模組化組裝的供應鏈，使其更靠近主要終端用戶市場。

從市場進入角度來看，關稅變化導致價值提案碎片化。供應商強調整體擁有成本、服務可靠性和整合耗材包，以在受關稅影響的環境下證明定價合理性。因此，行業變得更加防禦性，並進行了戰略多元化；區域製造商通過利用本地生產而不是依賴受關稅影響的進口產品來提升市場佔有率；而靈活的供應商則通過提供差異化服務和訂閱模式，看到了降低短期價格敏感性的機會。

將物種、診斷方式、終端用戶畫像和樣本採集路徑與可操作的產品和管道策略聯繫起來的全面細分洞察

透過從臨床、技術和商業性等多個角度審視市場，可以發現關鍵的細分市場洞察。依動物類型分類，需求模式可分為伴侶動物和牲畜兩大類。在伴侶動物領域，貓和狗由於看護者期望和臨床表現的差異，呈現出不同的診斷應用場景；而牲畜的需求涵蓋牛、馬、家禽和豬，它們往往更注重檢測通量、生物安全性和批量檢測流程。這些不同的需求會影響套件配方、分析儀通量和服務模式。

按檢測類型分類，生化檢測（包括生化和電解質分析儀）仍然是常規代謝篩檢和重症加護的基礎。血液學儀器（例如血球計數器和血紅蛋白分析儀）是貧血檢測和感染疾病監測的核心。免疫測量（如酵素連結免疫橫向流動化驗）提供快速簡便的篩檢，而分子診斷設備則在疫情爆發情況下提供更高的病原體檢測靈敏度和特異性。

最終使用者涵蓋範圍廣泛，包括診斷實驗室、醫院/診所和研究機構，每個機構的採購週期、驗證要求和預算各不相同。技術選項分為兩類：一類是基於讀卡機的系統，提供定量和連接功能；另一類是無讀卡機系統，優先考慮簡單性和低成本。應用領域涵蓋心臟監測、重症加護、感染疾病檢測和代謝篩檢，常見樣本類型包括血液、糞便、牛奶、唾液和尿液。了解這些細分維度如何相互交織，對於產品設計和市場推廣優先順序至關重要，因為分析儀功能、耗材規格和服務的最佳組合會因動物種類、測試目標和飼養環境的不同而顯著變化。

區域差異化視角，著重闡述全球主要區域在臨床需求、監管細微差別和商業性路徑上的差異

區域動態影響市場採納曲線、監管路徑和商業性優先事項，供應商和投資者在規劃市場進入和擴張時必須考慮這些因素。在美洲，市場需求主要集中在先進的伴侶動物護理和一體化的診所工作流程上，這得益於強大的私人獸醫網路以及對高階診斷技術的投資意願。該地區的市場新參與企業正著重強調儀器性能、數位化整合和耗材捆綁銷售等差異化優勢，同時，遠端保健診斷服務也呈現成長動能。

在歐洲、中東和非洲，買家面臨著監管環境、報銷標準和動物保健服務基礎設施等方面的顯著差異。西方市場往往更注重臨床的複雜性和監管主導的檢驗要求，而中東和北非市場則更重視產品的穩健性、成本效益和簡化的培訓模式。這些區域差異要求客製化的產品線和靈活的銷售條款，以適應不同的採購能力和臨床實踐。

在亞太地區，人口密度高、畜牧業蓬勃發展以及寵物飼養率不斷上升，推動了對擴充性診斷技術的需求。多個市場正在快速採用行動診斷和雲端分析技術，而一些國家強大的本地製造業基礎也為具有成本競爭力的耗材的快速部署提供了支援。整體而言，為了實現永續的普及應用，區域策略必須在利用全球技術平台的同時，兼顧區域產品客製化、監管協調和經銷夥伴。

對現有企業、獸醫專業公司和創新新興企業如何競爭與合作以獲得設備、耗材和服務方面的價值進行策略評估。

動物即時診斷領域呈現出多元化的格局，既有成熟的診斷服務提供商，也有專注於獸醫領域的專業公司，還有新興企業，它們各自採取不同的規模化發展路徑。成熟的設備製造商利用其成熟的分銷和服務能力，向上提升銷售儀器和耗材整合解決方案；而專注於獸醫領域的公司則專注於臨床檢驗和產品設計，使其與獸醫的工作流程相契合。新興企業通常專注於單一的高價值應用、新型檢測化學方法或能夠簡化結果解讀和報告的數位化技術。

策略活動的核心是夥伴關係、授權協議和共同開發契約，這些協議能夠加快產品上市速度並分散開發風險。常見的做法包括與獸醫院集團合作試行新的診斷方法，與契約製造製造商簽訂合約以實現本地化生產，以及與軟體供應商合作將連接性和分析功能嵌入到臨床常規流程中。競爭優勢越來越依賴提供端到端價值的能力，包括可靠的硬體、高效的耗材、快速反應的服務以及能夠提升臨床效用的數據工具。

那些簽訂長期服務協議、最佳化試劑物流並提供針對性臨床醫生教育計畫的公司往往能獲得較高的客戶留存率和更高的終身收益。相反，那些對本地支援投入不足或未能清楚展示臨床效益的公司，其產品推廣週期則會更長。評估夥伴關係的相關人員應重點關注營運準備、品質體係以及支援多物種檢驗的能力，以最大限度地提高跨領域適用性。

為供應商和投資者提供可操作的策略建議，以增強其獸醫診斷產品系列、供應鏈、服務模式和監管參與。

產業領導者可以透過實施一系列有針對性的策略行動來加速技術普及並確保永續的競爭優勢：能夠相容於多種檢測類型和樣本基質的平台可以降低單位風險並提高生命週期收益。投資開發無需讀卡機的低成本、大批量應用平台，同時保留用於定量互聯工作流程的讀卡機產品，可擴大市場覆蓋範圍並彈性價格設定。

第二，透過區域製造夥伴關係和多邊採購協議加強供應鏈韌性，以降低關稅波動和物流中斷帶來的風險。引入本地組裝和區域試劑生產可以縮短前置作業時間，並提高利潤穩定性。第三，透過整合培訓、校準和數位化解讀支援的服務模式實現差異化。基於訂閱的耗材計劃，包括自動補貨和遠端監控，可以提高客戶維繫，並穩定收益和預測。

第四，我們將積極與監管機構和關鍵意見領袖溝通，加快臨床檢驗，並制定清晰的市場推廣路徑。第五，我們將建構符合終端用戶經濟狀況的商業模式，提供分級儀器、捆綁式耗材和靈活的融資方案，以滿足獸醫診所、診斷實驗室和研究機構的不同預算需求。最後，我們將整合數據能力，將診斷結果轉化為可操作的臨床資訊和人群健康洞察，從而增強我們對購買者和支付者的價值提案。

對用於建構可操作情報的主要和次要研究方法、專家檢驗流程以及資料三角測量技術進行透明概述

本分析的調查方法結合了初步質性研究和嚴謹的二次檢驗，以確保研究結果具有臨床相關性和實際應用價值。初步研究包括對執業獸醫、實驗室主任、動物飼養經理和產品開發負責人進行結構化訪談，重點關注應用案例、採購決策標準和售後支援期望。這些訪談真實反映了現有診斷產品的可接受性、工作流程整合情況以及痛點。

二次研究利用技術文獻、監管指導文件、專利和公開的臨床檢驗研究來支持​​性能聲明並確定技術發展軌跡。採用數據三角測量法來協調各相關人員的觀點差異，並檢驗實務中觀察到的趨勢。透過將臨床應用案例與設備特性和耗材形式進行交叉比對，進行細分分析，以確定產品滿足最終用戶需求的領域。

調查方法的限制包括不同地區監管透明度的差異以及不同動物物種適應成熟度的差異，這可能會影響戰術性結論的普遍適用性。為了減輕這些局限性，我們透過情境分析對研究結果進行了壓力測試，並由獨立的行業專家進行同行評審，以提高所提建議的穩健性。

總結全文，重點闡述技術、服務提供和營運韌性之間的相互作用，這將決定獸醫診斷的長期成功。

總之，獸醫照護現場技術正步入實用化成熟階段，技術能力、服務設計和商業性彈性將決定最終的成敗。可攜式分子檢測工具、改進的免疫測量方法和數位化讀數平台的融合，為診斷技術從零星應用轉向在伴侶動物診所和畜牧業的常規應用提供了清晰的路徑。然而，能否持續普及應用取決於能否解決終端使用者的經濟問題、建構穩健的供應鏈，以及在各種環境下展現可衡量的臨床效用。

將模組化產品設計與強大的本地支援、智慧服務模式以及有助於獲得監管部門認可的夥伴關係關係相結合的組織，最有可能創造持久價值。關稅壓力和區域差異凸顯了靈活的製造地和適應性強的商業條款的重要性。最終，最具吸引力的價值提案是將快速、準確的診斷與改善臨床結果、減少營運浪費和加強人群健康監測聯繫起來，從而使即時檢測（POC​​）成為動物醫療保健運作整體不可或缺的一部分。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧影像分析技術整合到手持式獸醫診斷設備中，以提高準確性和速度
  • 寵物綜合現場疾病檢測中多重免疫檢測試劑盒的應用日益廣泛
  • 擴大攜帶式分子檢測平台的規模，以便在現場環境中快速檢測通用感染疾病。
  • 獸醫診所正在加大對無線連接的投資，以實現即時遠端監控和遠端醫療。
  • 推出一款基於智慧型手機的診斷感測器，用於早期檢測牲畜代謝紊亂疾病。
  • 能夠以極少的樣本量進行測量的照護現場生化分析儀對於新生兒和異寵來說變得越來越重要。
  • 農業技術和獸醫診斷公司合作開發用於牲畜健康監測的感測器陣列
  • 開發用於農場抗菌素抗藥性標記物檢測的電池供電微流體裝置
  • 獸醫診所擴大使用基於雲端基礎的分析技術，將即時檢驗（POC）數據與電子健康記錄相結合，進行趨勢分析。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：以動物類型分類的動物即時診斷市場

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 馬
    • 家禽
    • 豬

9. 按檢測類型分類的動物即時診斷市場

  • 生物化學
    • 化學分析儀
    • 電解質分析儀
  • 血液學
    • 細胞計數器
    • 血紅素分析儀
  • 免疫檢測
    • 伊麗莎
    • 橫向流動化驗
  • 分子診斷

第10章：以最終用戶分類的動物即時診斷市場

  • 診斷實驗室
  • 醫院和診所
  • 研究機構

第11章：按技術分類的動物即時診斷市場

  • 領導者
  • 無領導

第12章：按應用分類的動物即時診斷市場

  • 心臟監測
  • 加護治療
  • 感染疾病
  • 代謝篩檢

第13章：依樣本類型分類的動物即時診斷市場

  • 血
  • 屎
  • 牛奶
  • 唾液
  • 尿

第14章：按地區分類的獸醫即時診斷市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 動物即時診斷市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國動物即時診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Heska Corporation
    • Abaxis, Inc.
    • Mars, Inc.
    • FUJIFILM Holdings Corporation
    • Nova Biomedical Corporation
    • bioMerieux SA
    • Abbott Laboratories
    • QIAGEN NV
Product Code: MRR-3A2E844FD625

The Veterinary Point Of Care Diagnostics Market is projected to grow by USD 5.03 billion at a CAGR of 12.58% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.94 billion
Estimated Year [2025] USD 2.19 billion
Forecast Year [2032] USD 5.03 billion
CAGR (%) 12.58%

A succinct introduction framing how bedside and barnside diagnostics are reshaping veterinary care delivery and clinical decision making today

Veterinary point-of-care diagnostics are rapidly transitioning from niche adjuncts to core elements of animal healthcare delivery. Vets and livestock managers increasingly demand fast, reliable test results at the bedside or barn to enable immediate clinical decisions, improve throughput, and reduce the logistical friction associated with centralized laboratories. Advances in portable assay chemistry, miniaturized analyzers, and integrated digital output have compressed turnaround times and allowed for meaningful diagnostics at the time and place of care.

This evolution is driven by several converging forces. Rising companion animal ownership and heightened willingness to invest in pet health are reshaping clinical expectations, while intensifying pressure to optimize herd health and biosecurity in livestock sectors is pushing farm managers to adopt more proactive diagnostic workflows. Concurrently, technological maturation across immunoassays, molecular platforms, and sensor technologies has enabled greater analytical performance in compact formats. Regulatory clarity in some jurisdictions and expanding training programs for veterinary professionals are reducing barriers to adoption.

Taken together, these dynamics are enabling practitioners to close the gap between clinical suspicion and verification, supporting earlier interventions, more targeted therapeutics, and measurable improvements in animal welfare and operational efficiency. The remainder of this executive summary examines the transformational shifts, segmentation nuances, regional differences, corporate responses, and strategic recommendations that leaders must weigh when engaging this dynamic market.

An analysis of the pivotal technological, clinical, and commercial shifts that are redefining point-of-care veterinary diagnostics and industry business models

The landscape of veterinary point-of-care diagnostics is undergoing transformative shifts that reconfigure value chains, clinical workflows, and investment priorities. One prominent change is the migration from single-use lateral flow devices toward more sophisticated reader-based and reader-less formats that enable quantitative outputs, connectivity, and result standardization. This shift supports integration with practice management systems and teletriage services, allowing clinicians to make data-driven decisions with confidence and to extend diagnostic reach into remote and ambulatory settings.

Simultaneously, molecular diagnostics are moving out of centralized labs and into near-patient environments, driven by simplified sample preparation, isothermal amplification methods, and cartridgeized consumables. The democratization of higher-sensitivity tests alters diagnostic pathways for infectious disease management in both companion animals and livestock, enabling faster containment and targeted therapeutics. Artificial intelligence and cloud analytics are adding a layer of interpretation to raw outputs, helping clinicians prioritize cases and identify epidemiological signals earlier.

As business models evolve, manufacturers and distributors are adopting service-centric approaches that bundle instruments with reagents, calibration services, and digital subscriptions to lock in lifetime value and improve predictability. These shifts are forcing legacy vendors to accelerate innovation cycles and newer entrants to demonstrate clinical validation, regulatory compliance, and cost-effective service operations. The aggregate result is a more connected, agile, and clinically impactful diagnostic ecosystem for animal health.

How the 2025 tariff adjustments reshaped supply chains, pricing strategies, and procurement choices across veterinary diagnostic equipment and consumables

The cumulative impact of tariff changes implemented in 2025 has materially influenced procurement strategies, pricing mechanisms, and supply chain resilience across the veterinary diagnostics ecosystem. Tariff dynamics have increased the landed cost of imported analyzers, reader modules, and critical reagent inputs that are often manufactured in highly specialized overseas facilities. For end users operating on tight margins, such as ambulatory clinics and small diagnostic laboratories, incremental cost increases create pressure to reprice services or lengthen replacement cycles for capital equipment.

Manufacturers and distributors responded by accelerating localization and dual-sourcing strategies. Some moved production of high-volume consumables to regional contract manufacturers, while others prioritized inventory hedging and multi-tier distribution to buffer short-term volatility. These maneuvers improved responsiveness but increased working capital requirements and added complexity to inventory management. In parallel, tariff-related cost pressures incentivized product redesigns that reduced reliance on tariffed components and optimized supply chains for modular assembly closer to major end-user markets.

From a market access viewpoint, tariff changes encouraged a sharper segmentation of value propositions. Vendors emphasized total cost of ownership, service reliability, and integrated consumables bundles to justify pricing in tariff-inflated environments. The net effect is a more defensive and strategically diversified industry posture, with opportunities for regional manufacturers to capture share where local production can undercut tariff-affected imports and for agile suppliers to offer differentiated service and subscription models that dampen immediate price sensitivity.

A comprehensive set of segmentation insights tying animal species, diagnostic modalities, end-user profiles, and sample pathways to actionable product and channel strategies

Key segmentation insights emerge when the market is examined through multiple lenses that reflect clinical, technological, and commercial realities. By animal type, demand patterns bifurcate between companion animals and livestock; within the companion segment, cats and dogs exhibit distinct diagnostic use cases driven by differences in caregiver expectations and clinical presentation, while livestock demands-spanning cattle, horses, poultry, and swine-tend to prioritize throughput, biosecurity, and batch testing workflows. These divergent needs affect kit formulation, analyzer throughput, and service models.

When tests are disaggregated by type, biochemistry solutions, which include chemistry analyzers and electrolyte analyzers, remain foundational for routine metabolic screening and critical care. Hematology instruments such as cell counters and hemoglobin analyzers are core to anemia workup and infection monitoring. Immunoassays continue to serve as rapid, easy-to-use screens delivered via ELISA formats or lateral flow assays, while molecular diagnostics provide higher sensitivity and specificity for pathogen detection in outbreak scenarios.

End users skew across diagnostic laboratories, hospitals and clinics, and research institutes, each with different procurement cycles, validation requirements, and budget horizons. Technology choices split between reader-based systems that deliver quantitation and connectivity, and reader-less formats that prioritize simplicity and low cost. Applications span cardiac monitoring, critical care, infectious disease detection, and metabolic screening, with sample types commonly including blood, feces, milk, saliva, and urine. Understanding how these segmentation axes intersect is central to product design and go-to-market prioritization because the optimal combination of analyzer capability, consumable format, and service offering varies significantly by animal type, test purpose, and care setting.

A regionally differentiated view highlighting the distinct clinical demands, regulatory nuances, and commercial pathways across major global territories

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in ways that vendors and investors must account for when planning market entry and expansion. In the Americas, demand is concentrated around advanced companion animal care and integrated clinic workflows, supported by strong private veterinary practice networks and a willingness among owners to invest in premium diagnostics. Market participants in this region emphasize instrument performance, digital integration, and bundled consumables as differentiators, and there is growing momentum for telehealth-enabled diagnostic services.

Across Europe, the Middle East & Africa, purchasers face a diverse landscape marked by high variability in regulatory frameworks, reimbursement norms, and veterinary service infrastructure. Western European markets trend toward clinical sophistication and regulation-driven validation requirements, while certain Middle Eastern and African markets prioritize ruggedness, cost efficiency, and simplified training models. These regional contrasts require tailored product lines and flexible commercial terms to accommodate heterogeneous procurement capabilities and clinical practices.

In the Asia-Pacific region, high population densities, expanding livestock operations, and rising companion animal ownership create strong demand for scalable diagnostics. Several markets show rapid adoption of mobile-enabled diagnostics and cloud analytics, and a robust local manufacturing base in some countries has supported faster rollout of cost-competitive consumables. Overall, regional strategies must balance global technology platforms with localized product adaptations, regulatory alignment, and distribution partnerships to achieve sustainable penetration.

A strategic assessment of how incumbents, specialized veterinary firms, and innovative startups are competing and collaborating to capture value across instruments, consumables, and services

The corporate landscape in veterinary point-of-care diagnostics is characterized by a blend of established diagnostics providers, specialized veterinary focused firms, and nimble startups, each pursuing different routes to scale. Incumbent device manufacturers leverage established distribution networks and service capabilities to upsell integrated instrument-and-consumable solutions, while specialized veterinary firms emphasize clinical validation and tailored product design to meet practitioner workflows. Startups frequently focus on single high-value applications, novel assay chemistries, or digital layers that simplify interpretation and reporting.

Strategic activity centers on partnerships, licensing, and co-development agreements that accelerate time to market while spreading development risk. Common approaches include collaborations with veterinary hospital groups to pilot new diagnostics, agreements with contract manufacturers to regionalize production, and alliances with software providers to embed connectivity and analytics into clinical routines. Competitive differentiation increasingly relies on the ability to deliver end-to-end value: reliable hardware, validated consumables, responsive service, and data tools that drive clinical utility.

Firms that secure long-term service contracts, optimize reagent logistics, and provide targeted clinician education programs tend to achieve higher retention and improved lifetime revenue. Conversely, companies that underinvest in local support or fail to demonstrate clear clinical advantages face protracted adoption cycles. For stakeholders evaluating partnerships, emphasis should be placed on operational readiness, quality systems, and the ability to support multi-species validation to maximize cross-segment applicability.

Actionable strategic recommendations for vendors and investors to strengthen product portfolios, supply chains, service models, and regulatory engagement in veterinary diagnostics

Industry leaders can accelerate adoption and secure durable advantage by implementing a focused set of strategic actions. First, prioritize product architectures that offer modularity: platforms capable of supporting multiple assay types and sample matrices reduce per-unit risk and increase life cycle revenues. Investing in reader-less formats for low-cost, high-volume use while maintaining reader-based offerings for quantitative and connected workflows enables broader market coverage and pricing flexibility.

Second, strengthen supply chain resilience through regional manufacturing partnerships and multilateral sourcing agreements that reduce exposure to tariff volatility and logistical disruption. Embedding local assembly and regional reagent production can shorten lead times and improve margin stability. Third, differentiate through service models that integrate training, calibration, and digital interpretive support; subscription-based consumable plans that include automatic replenishment and remote monitoring improve customer retention and stabilize revenue forecasts.

Fourth, engage proactively with regulators and key opinion leaders to accelerate clinical validation and create clear pathways for market access. Fifth, align commercial models to end-user economics by offering tiered instruments, bundled consumables, and flexible financing to accommodate varied budget profiles across veterinary clinics, diagnostic laboratories, and research institutes. Finally, embed data capabilities to convert diagnostic outputs into actionable practice intelligence and population health insights, thereby reinforcing the value proposition for buyers and payers alike.

A transparent outline of primary and secondary research approaches, expert validation processes, and data triangulation techniques used to build actionable intelligence

The research methodology underpinning this analysis combines primary qualitative inquiry with rigorous secondary validation to ensure findings are clinically relevant and operationally grounded. Primary research included structured interviews with practicing veterinarians, laboratory directors, livestock production managers, and product development leaders, focusing on use cases, procurement decision criteria, and post-purchase support expectations. These conversations provided real-world context for product acceptance, workflow integration, and pain points associated with existing diagnostic offerings.

Secondary research drew on technical literature, regulatory guidance documents, patents, and publicly available clinical validation studies to corroborate performance claims and identify technology trajectories. Data triangulation was employed to reconcile differing perspectives across stakeholder groups and to validate trends observed in practice. Segmentation analyses were performed by cross-referencing clinical use cases with instrumentation capabilities and consumables formats to determine where product fit aligns with end-user needs.

Limitations of the methodology include variability in regulatory transparency across regions and differing levels of adoption maturity across animal types, which can affect the generalizability of some tactical conclusions. To mitigate these constraints, findings were stress-tested through scenario analysis and subjected to peer review by independent industry experts, enhancing the robustness of the recommendations presented.

A conclusive synthesis emphasizing the interplay of technology, service delivery, and operational resilience that will determine long-term success in veterinary diagnostics

In conclusion, veterinary point-of-care diagnostics are entering a phase of practical maturation where technological capability, service design, and commercial agility determine winners and losers. The convergence of portable molecular tools, improved immunoassay formats, and digital interpretation platforms provides a clear pathway for diagnostics to move from episodic use toward routine integration in both companion animal clinics and livestock operations. However, sustained adoption depends on addressing end-user economics, building resilient supply chains, and demonstrating measurable clinical utility across multi-species contexts.

Organizations that combine modular product design with strong local support, intelligent service models, and partnerships that accelerate regulatory acceptance will be best positioned to capture durable value. Tariff pressures and regional variability underscore the need for flexible manufacturing footprints and adaptive commercial terms. Ultimately, the most compelling value propositions will be those that translate rapid, accurate diagnostics into improved clinical outcomes, reduced operational waste, and enhanced population health surveillance, thereby making point-of-care testing indispensable across animal health practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-powered image analysis in handheld veterinary diagnostics to enhance accuracy and speed
  • 5.2. Rising adoption of multiplex immunoassay cartridges for comprehensive on-site disease panels in companion animals
  • 5.3. Expansion of portable molecular testing platforms enabling rapid detection of zoonotic pathogens in field conditions
  • 5.4. Increased investment in wireless connectivity features for real-time remote monitoring and telemedicine in veterinary clinics
  • 5.5. Deployment of smartphone-based diagnostic sensors for early detection of metabolic disorders in livestock
  • 5.6. Growing emphasis on point-of-care biochemical analyzers with minimal sample volume for neonatal and exotic pets
  • 5.7. Collaboration between agtech and veterinary diagnostics firms to develop sensor arrays for herd health management
  • 5.8. Development of battery-operated microfluidic devices for on-farm detection of antimicrobial resistance markers
  • 5.9. Surge in availability of cloud-based analytics integrating POC data with electronic health records for trend analysis within veterinary practice

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Cattle
    • 8.2.2. Horses
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Test Type

  • 9.1. Biochemistry
    • 9.1.1. Chemistry Analyzer
    • 9.1.2. Electrolyte Analyzer
  • 9.2. Hematology
    • 9.2.1. Cell Counter
    • 9.2.2. Hemoglobin Analyzer
  • 9.3. Immunoassay
    • 9.3.1. Elisa
    • 9.3.2. Lateral Flow Assay
  • 9.4. Molecular Diagnostics

10. Veterinary Point Of Care Diagnostics Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals And Clinics
  • 10.3. Research Institutes

11. Veterinary Point Of Care Diagnostics Market, by Technology

  • 11.1. Reader Based
  • 11.2. Reader Less

12. Veterinary Point Of Care Diagnostics Market, by Application

  • 12.1. Cardiac Monitoring
  • 12.2. Critical Care
  • 12.3. Infectious Disease
  • 12.4. Metabolic Screening

13. Veterinary Point Of Care Diagnostics Market, by Sample Type

  • 13.1. Blood
  • 13.2. Feces
  • 13.3. Milk
  • 13.4. Saliva
  • 13.5. Urine

14. Veterinary Point Of Care Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Point Of Care Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Heska Corporation
    • 17.3.4. Abaxis, Inc.
    • 17.3.5. Mars, Inc.
    • 17.3.6. FUJIFILM Holdings Corporation
    • 17.3.7. Nova Biomedical Corporation
    • 17.3.8. bioMerieux SA
    • 17.3.9. Abbott Laboratories
    • 17.3.10. QIAGEN N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY POINT OF CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY POINT OF CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET